Company registration number 14067148 (England and Wales)
HMHM PHARMA LTD.
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
HMHM PHARMA LTD.
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
HMHM PHARMA LTD.
BALANCE SHEET
AS AT 31 MARCH 2026
31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
3
449
494
Investments
4
997,147
997,147
997,596
997,641
Current assets
Cash at bank and in hand
913
278
Creditors: amounts falling due within one year
5
(961,145)
(959,476)
Net current liabilities
(960,232)
(959,198)
Net assets
37,364
38,443
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
37,264
38,343
Total equity
37,364
38,443

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 4 August 2026
Miss HK Cheng
Director
Company registration number 14067148 (England and Wales)
HMHM PHARMA LTD.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 2 -
1
Accounting policies
Company information

HMHM PHARMA LTD. is a private company limited by shares incorporated in England and Wales. The registered office is 504 Linter Building, 44 Whitworth Street, Manchester, United Kingdom, M1 3AJ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

HMHM PHARMA LTD.
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 3 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
Over the lease period

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.7

Related party exemption

The company has taken advantage of the exemption, under the terms of Financial Reporting Standard 102,' The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

HMHM PHARMA LTD.
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
1
1
3
Tangible fixed assets
Leasehold land and buildings
£
Cost
At 1 April 2025 and 31 March 2026
629
Depreciation and impairment
At 1 April 2025
135
Depreciation charged in the year
45
At 31 March 2026
180
Carrying amount
At 31 March 2026
449
At 31 March 2025
494
4
Fixed asset investments
2026
2025
£
£
Shares in group undertakings and participating interests
997,147
997,147
5
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
960
960
Amounts owed to group undertakings
152,379
149,314
Taxation and social security
-
0
42
Other creditors
807,806
809,160
961,145
959,476
2026-03-31 2025-04-01 false false false 04 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Miss HK Cheng 14067148 2025-04-01 2026-03-31 14067148 2026-03-31 14067148 2025-03-31 14067148 core:LandBuildings 2025-03-31 14067148 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 14067148 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 14067148 core:CurrentFinancialInstruments 2026-03-31 14067148 core:CurrentFinancialInstruments 2025-03-31 14067148 core:ShareCapital 2026-03-31 14067148 core:ShareCapital 2025-03-31 14067148 core:RetainedEarningsAccumulatedLosses 2026-03-31 14067148 core:RetainedEarningsAccumulatedLosses 2025-03-31 14067148 bus:Director1 2025-04-01 2026-03-31 14067148 core:LandBuildings core:LongLeaseholdAssets 2025-04-01 2026-03-31 14067148 2024-04-01 2025-03-31 14067148 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-03-31 14067148 core:LandBuildings core:LeasedAssetsHeldAsLessee 2026-03-31 14067148 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-04-01 2026-03-31 14067148 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 14067148 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 14067148 bus:FRS102 2025-04-01 2026-03-31 14067148 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 14067148 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP